Recent 8-K filings for CRVW
Highest-materiality recent filing
CareView converts $26.2M of Replacement Notes into 262M shares at $0.10/share
- Majority and minority investors converted $26.2M Replacement Notes into 262M shares at $0.10/share; lockup ends Dec 31, 2023.
- HealthCor Parties initially convert only 50% of their Notes; remaining 50% awaits stockholder approval to increase authorized shares from 500M to 800M.
-
CareView extends credit agreement maturity to September 30, 2026 via Fifteenth Amendment
Maturity Date extended from June 30, 2026 to September 30, 2026 under Fifteenth Amendment.
-
CareView extends credit agreement maturity to June 30, 2026
Fourteenth Amendment to Credit Agreement extends Maturity Date to June 30, 2026.
-
CareView extends credit agreement maturity to March 31, 2026 under Thirteenth Amendment
Maturity date extended to March 31, 2026 via Thirteenth Amendment to Credit Agreement with PDL Investment Holdings.
-
CareView extends credit agreement maturity to Dec 31, 2025 via Twelfth Amendment
Twelfth Amendment to Credit Agreement executed Sept 30, 2025, extending Maturity Date to December 31, 2025.
-
CareView extends credit maturity to September 30, 2025 via Eleventh Amendment
Eleventh Amendment to Credit Agreement extends Maturity Date to September 30, 2025.
-
CareView extends credit agreement maturity date to June 30, 2025
Tenth Amendment extends Maturity Date to June 30, 2025, from earlier date.
-
CareView extends credit facility maturity to March 31, 2025 via Ninth Amendment
Ninth Amendment to Credit Agreement executed on December 11, 2024 extends Maturity Date to March 31, 2025.
-
CareView adopts 2024 Stock Incentive Plan, grants 29.8M options at $0.06; COO receives 8.9M options
Board approved 2024 Stock Incentive Plan authorizing 30,000,000 shares for awards effective March 5, 2024.
-
CareView amends credit agreement: PIK interest, mandatory prepayments, maturity extended to Dec 2024
Accrued interest on Tranche One and Three loans to be paid-in-kind (added to principal) instead of cash.
-
CareView noteholders convert $18M notes to 180M shares at $0.10 per share
Noteholders converted $18,000,000 Replacement Notes into 180,000,000 common shares on May 24, 2023 at $0.10/share.
-
CareView Communications enters 30th amendment to credit modification agreement
Thirtieth Amendment entered on April 29, 2023; specific terms not detailed in filing text.
-
CareView enters 29th amendment to credit agreement, extending forbearance again
Twenty-Ninth Amendment to Modification Agreement entered on March 31, 2023.
-
CareView converts $26.2M of debt into 262M shares at $0.10 per share
Converted $26.2M aggregate principal of Replacement Notes into 262M shares of common stock at $0.10/share.
-
CareView converts $26.2M of Replacement Notes into 262M shares at $0.10/share
Majority and minority investors converted $26.2M Replacement Notes into 262M shares at $0.10/share; lockup ends Dec 31, 2023.
-
Filing reports entry into Twenty-Sixth Amendment to Modification Agreement with lender PDL Investment Holdings.
-
CareView exchanges $88.3M debt and warrants for $44.9M replacement notes
Aggregate $88.3M notes and ~15.4M share warrants cancelled; replaced with $44.9M senior secured convertible notes.
-
CareView enters 26th amendment to credit modification agreement; terms not disclosed
Filing reports Twenty-Sixth Amendment to Modification Agreement dated Dec 30, 2022.
-
CareView raises $250k via private placement of 2.5M shares at $0.10/share to directors
Sold 2,500,000 shares of common stock at $0.10 per share for aggregate proceeds of $250,000.
-
CareView Communications dismisses BDO, appoints RRBB as new auditor effective Aug 24, 2022
Dismissed BDO USA LLP and appointed Rosenberg Rich Baker Berman as principal independent auditor, effective Aug 24, 2022.
-
CareView Communications dismisses BDO USA, engages RRBB as new auditor
BDO USA dismissed as auditor; its 2021/2020 reports contained a going concern paragraph.
-
On July 12, 2022, CareView entered into allonges suspending interest accrual on 2014-2020 convertible notes.
-
CareView enters 26th credit amendment, extends forbearance and defers interest again
Company and lender agreed to 26th Amendment to Modification Agreement on June 23, 2022.
-
CareView extends HealthCor Notes maturity to April 2023, issues 3M warrants at $0.09/share
Extended maturity of 2011 and 2012 HealthCor Notes from April 20, 2022 to April 20, 2023.
-
CareView enters 25th Amendment to Modification Agreement; terms undisclosed
Filed 8-K on Nov 29, 2021 for Twenty-Fifth Amendment to Modification Agreement with lender PDL Investment Holdings.
Materiality & sentiment trend
Max materiality 0.90 · Median 0.60 · Most common event debt